Koch-Henriksen N. It is safe to switch therapy from interferon beta or glatiramer acetate to oral therapy in patients with relapsing multiple sclerosis with stable disease. J Neurol Neurosurg Psychiatry 2021 Feb 9. pii: jnnp-2020-325684.
PMID: 33563802